8/11/2022  12:00:00 AM Chg. -46.00 Volume Bid5:29:41 PM Ask5:29:41 PM Market Capitalization Dividend Y. P/E Ratio
1,297.00SEK -3.43% 584,961
Turnover: 764.75 mill.
1,296.00Bid Size: - 1,297.00Ask Size: - 2008.41 bill.SEK - -

Business description

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
 

Management board & Supervisory board

CEO
Pascal Soriot
Management board
Aradhana Sarin, David Fredrickson, Iskra Reic, Jeff Pott, Katarina Ageborg, Leon Wang, Marc Dunoyer, Menelas Pangalos, Pam Cheng, Ruud Dobber, Susan Galbraith
Supervisory board
Leif Johannson, Andreas Rummelt, Aradhana Sarin, Deborah DiSanzo, Diana Layfield, Euan Ashley, Marcus Wallenberg, Michel Demaré, Nazneen Rahman, Pascal Soriot, Philip Broadley, Sheri McCoy, Tony Mok
 

Company data

Name: AstraZeneca plc
Address: 2 Kingdom Street,UK-London W2 6BD
Phone: +44-20-7604-8000
Fax: +44-20-7604-8151
E-mail: -
Internet: www.astrazeneca.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 77.64%
IPO date: -

Investor relations

Name: Chris Sheldon
IR phone: +44-203-749-5712
IR Fax: -
IR e-mail: IR@astrazeneca.com

Company calendar

CW 38 | 9/12/2022 Dividend Payment
CW 46 | 11/10/2022 Interim Report 1st Quarter/3 Months
 

Main Shareholders

Freefloat
 
77.64%
BlackRock, Inc.
 
6.51%
Wellington Management Group LLP
 
4.20%
Wellington Management Company LLP
 
4.20%
The Capital Group Companies, Inc.
 
4.12%
Investor AB
 
3.33%